Best Healthcare AI Software for Mid Size Business - Page 4

Omnipractice is a cloud-based electronic health record and practice management system powered by AI, aimed at optimizing both clinical and administrative processes for healthcare professionals, particularly in the realms of behavioral health, addiction treatment, and multi-specialty practices. This comprehensive platform integrates essential functions like client intake, CRM lead tracking, scheduling, secure portals for clients and therapists, billing processes, e-prescribing, and analytical dashboards into one HIPAA-compliant solution, enabling teams to minimize manual tasks and enhance operational efficiency. Among its innovative features, Omnipractice offers an advanced AI scribe and notes system that can effortlessly transcribe sessions, create progress notes and treatment plans from templates, and allow clinicians to modify the outputs as needed; it also includes custom AI Studio workflows, automatic form completion, support for group notes, and streamlined insurance verification, claims processing, and eligibility checks. The platform's design not only prioritizes user experience but also aims to facilitate seamless communication among healthcare providers and their clients. By harnessing the power of artificial intelligence, Omnipractice ultimately seeks to revolutionize how healthcare services are delivered and managed.

Arterys is an innovative medical imaging AI platform that seamlessly integrates advanced AI clinical applications into your existing PACS or EHR workflows, making it an intuitive extension of your current practices. Our goal is to bring AI into the forefront by enhancing physician experiences, improving diagnostic accuracy and treatment efficacy, optimizing financial outcomes, and providing significant benefits for both patients and healthcare providers. Accessible from any validated device through the cloud, it offers rapid performance and easy deployment without the exchange of PHI, ensuring complete security. Fully connected to PACS, RIS, EMR, and dictation software, Arterys enhances your workflow without disruption. Its rapid deployment capabilities require minimal on-premise infrastructure, and it is commercially available in more than 100 countries. The platform's elastic cloud GPU architecture significantly boosts the performance of various tasks, such as rendering complex 3D files, handling large multi-dimensional datasets, and executing multiple AI applications simultaneously in real time. Additionally, features like pre-fetching and image caching contribute to quicker loading times and more efficient analysis, making it an indispensable tool in modern healthcare. This comprehensive approach positions Arterys as a leader in transforming medical imaging through artificial intelligence.

Artera, a leading SaaS innovator in digital health, revolutionizes the patient experience with AI-driven virtual agents (both voice and text) designed to enhance every stage of the patient journey. Trusted by over 900 healthcare organizations—including specialty practices, FQHCs, large IDNs, and federal agencies—Artera engages with 100 million patients every year. Their virtual agents assist front desk teams by streamlining tasks such as self-scheduling, intake, forms, billing, and more. Whether boosting an existing team or deploying a fully autonomous digital workforce, Artera provides versatile virtual agent solutions tailored to fit where healthcare providers stand in their AI adoption. Supporting 2 billion communications annually across 109 languages on voice, text, and web, Artera combines a decade of healthcare expertise with cutting-edge AI to empower better care delivery.

Easily design, construct, oversee, and enhance secure, HIPAA-compliant healthcare applications driven by conversational AI solutions. The Orbita Prototype module facilitates no-code prototyping for conversation dialogues tailored for both voice and chat platforms. Users can share their designs and work collaboratively with project stakeholders while gathering valuable insights from end-users. The Orbita Experience Designer module allows developers to craft conversational applications using a low-code drag-and-drop interface, making it simple to utilize pre-built components for seamless integration with enterprise systems. Additionally, the Orbita Experience Manager module provides business and clinical professionals with tools to manage conversational experiences through intuitive ‘what you see is what you get’ (WYSIWYG) authoring tools and pre-designed templates for deploying surveys and other applications. Furthermore, the Orbita FAQ Hub module empowers users to efficiently create conversational voice and chatbot applications that focus on effective question-answering, all built upon a robust knowledge management framework. This comprehensive suite of modules ensures that healthcare organizations can swiftly adapt to the evolving needs of their patients and stakeholders.

Verily Lightpath has been crafted to function as a proactive, highly personalized, and adaptable chronic care platform, driven by ongoing data integration and artificial intelligence. However, Lightpath is not merely a standalone technology; it is complemented by a robust team of health coaches and a skilled clinical workforce comprising endocrinologists, pharmacists, primary care physicians, nurses, and registered dietitians. This collaborative approach enables Lightpath to address various levels of health needs within one comprehensive solution tailored to individual member requirements. The platform's care modules and pathways are designed to be both dynamic and personalized, utilizing AI to evolve as a self-learning system. The primary objective is to assist members in reaching their health goals by fostering behavior change through swift feedback mechanisms. Consequently, Lightpath is well-equipped to help members navigate obstacles, whether in collaboration with their existing healthcare providers or through engagement with our expert clinical care teams. This multifaceted support structure aims to enhance the overall experience and outcomes for each member.

Thoughtful AI presents an all-encompassing, AI-powered approach to managing healthcare revenue cycles (RCM). Featuring advanced AI agents like EVA for verifying eligibility and CAM for handling claims, this platform streamlines even the most intricate and labor-intensive RCM tasks. Aimed at enhancing both efficiency and precision, it lowers operational costs, decreases denial rates, and speeds up the posting of payments. Endorsed by top healthcare organizations, Thoughtful AI ensures smooth integration, promises a return on investment, and effectively cuts down costs associated with collections, all while adhering to HIPAA-compliant security standards and offering performance-based assurances. This innovative solution is transforming the way healthcare providers manage their financial processes.

mPower Clinical Analytics, created by Nuance and seamlessly integrated with Microsoft’s Azure platform, is a sophisticated analytics tool aimed at optimizing radiology workflows. This solution empowers healthcare providers to derive meaningful insights from unstructured clinical data, ultimately leading to better decision-making and enhanced operational efficiency. Utilizing artificial intelligence and machine learning, mPower Clinical Analytics plays a crucial role in recognizing trends, forecasting results, and refining processes in radiology departments. As a result, it not only boosts productivity but also contributes to improved patient care outcomes.

NVISO stands out as a pioneer in the realm of artificial intelligence focused on human behavior, catering to manufacturers of products and services that prioritize user experience on a global scale. Their technology, which has been thoroughly validated and deployed internationally, boasts remarkable accuracy for critical applications, including ensuring the safety of autonomous vehicles like Tesla's electric models through interior monitoring systems. Additionally, it plays a vital role in patient monitoring within remote telemedicine, benefiting both healthcare and robotics sectors. By supplying financial advisors with scientifically validated tools, NVISO enhances their ability to offer advice that aligns with clients' best interests, effectively detecting and managing client behaviors. Moreover, NVISO's innovations bolster the safety, security, and ease of use for connected and autonomous vehicles through sophisticated detection, authentication, and monitoring of drivers and passengers. Furthermore, the company's cutting-edge solutions equip medical professionals with intelligent patient monitoring systems, ultimately driving improved patient outcomes while enhancing operational efficiency in aged-care facilities and hospitals. This multifaceted approach positions NVISO as an invaluable partner in advancing technology across various sectors while prioritizing human-centered design.

Watson Health leverages its foundational strengths, extensive expertise in the healthcare sector, and cutting-edge technological offerings—such as AI, blockchain, and data analytics—to empower clients in their digital transformation journeys. By integrating innovative technology with seasoned consulting services, we assist organizations in becoming more efficient and resilient, ultimately enhancing their ability to fulfill their commitments to the communities they serve. Explore the Watson Health solutions designed to optimize clinical, financial, and operational effectiveness while also applying analytics to improve initiatives aimed at vulnerable populations. Additionally, our offerings enhance clinical trials and facilitate the generation of real-world evidence, which is crucial for advancing healthcare practices. We also provide solutions that enable payers to effectively manage performance, member engagement, and business networks. Furthermore, Watson Health assists organizations with benefits analytics and ensuring business continuity, making us a comprehensive partner in the healthcare landscape. This multifaceted approach highlights our commitment to driving positive outcomes across various facets of health systems and enhancing overall service delivery.

Primarily, the nxtHealth Smart Technologies for Telehealth enhances patient care by extending the therapeutic experience beyond traditional clinical environments. The nxtHealth APPS offer continuous care through features that enable measurement, data collection, reporting, and exercise guidance directly on mobile devices. For instance, the nxtHealth WEARBLS work in tandem with the APPS by providing valuable data from wearable sensors. These APPS and WEARBLS are integrated smoothly via a HIPAA-compliant backend, which includes a provider portal equipped with advanced data ANALYTX capabilities. Additionally, nxtHealth enhances the quality of data, communication between patients and providers, and overall care quality through its user-friendly design and seamless integration. Furthermore, nxtHealth comprises a comprehensive array of smart technologies for telehealth aimed at supporting patient-reported outcomes (PRO), cognitive assessments, and rehabilitation efforts, ensuring a holistic approach to patient wellness.

Reliable information is obtained from reputable sources like the Mayo Clinic and NHS, ensuring the delivery of precise content, while industry-specific NLP and NLG technologies facilitate engaging dialogues. Sensely's Insight Engine gathers user preferences to enhance the personalization of interactions. The dashboards leverage up-to-date information, offering instant and real-time insights regarding user behavior and patterns. With user-friendly design tools, customization and the creation of new interactions become effortless. Characters play a crucial role in bridging the divide between high-touch human engagement and more basic bots, providing a unique identity for your brand. Users have the capability to check symptoms and, if needed, connect with a live nurse to assist them. They also benefit from self-care options derived from a comprehensive database of medical knowledge, which empowers them to make informed health decisions. This multifaceted approach not only improves user experience but also fosters a deeper connection between technology and personal healthcare.

InformAI specializes in artificial intelligence solutions designed to enhance medical diagnostics at the point-of-care and boost the efficiency of radiologists. Our advanced AI-driven image classifiers and predictions related to patient outcomes are developed in collaboration with the Texas Medical Center, which is the largest medical center complex globally. Through partnerships with esteemed healthcare organizations, prominent physician associations, and top medical imaging firms, InformAI is revolutionizing healthcare delivery. Our team is made up of experts in the fields of healthcare, medicine, and artificial intelligence, working together to create innovations that lead to better patient results. One of our notable products, the InformAI Sinus Image Classifier, utilizes a 3D convolutional neural network (CNN) and is trained on a comprehensive library of 6 million radiology-validated 3D CT-scan images, showcasing our commitment to leveraging cutting-edge technology in the medical field. This approach not only enhances diagnostic accuracy but also contributes to more timely and effective patient care.

BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.

Transform your digital health offerings with our adaptable AI solutions. We aim to revolutionize healthcare by making it smarter and more preventive, utilizing cutting-edge technology, artificial intelligence, and seamless engagement platforms throughout the entire care spectrum. Babylon is developing innovative tools that can be integrated into your digital ecosystem, ensuring patients enjoy a fluid and cohesive experience. By joining forces, we can achieve superior clinical outcomes for your patient population through enhanced care integration and increased consumer engagement. Schedule a Babylon Video Appointment at any time, free of charge for those with certain health insurance plans. If Babylon isn't available through your insurance, you can still benefit from our complimentary chatbot and health assessment services. Transitioning the healthcare paradigm from a reactive to a preventive approach can lead to improved health outcomes and lower expenses. This is why we are merging AI-driven technology with human medical expertise to provide comprehensive healthcare solutions directly from your device, ensuring a holistic approach to well-being. Additionally, we are committed to making healthcare accessible to everyone, thus fostering a healthier community overall.

The red dot® algorithm we utilize swiftly identifies and highlights irregularities in images with remarkable precision. This advanced AI system has been crafted using a dataset of over 30,000 images, all meticulously evaluated by certified Consultant Radiologists from the UK. With continuous refinement by these highly skilled professionals, our red dot® algorithm maintains an impressive accuracy rate exceeding 90%. The ability to detect abnormalities in mere seconds ensures that patients receive diagnoses even before they leave the hospital. Furthermore, our AI technology enhances current reporting processes and seamlessly integrates with existing Radiology Information Systems (RIS) or Picture Archiving and Communication Systems (PACS), regardless of the vendor. Behold.ai has proven to be a highly cost-efficient solution, effectively alleviating reporting backlogs and capacity challenges while being up to 50% less expensive than outsourced reporting options. Recognized globally, behold.ai has earned a spot among the Top 100 Digital Health companies and is one of only five selected for AI diagnosis worldwide, showcasing its commitment to innovation in healthcare. This recognition underscores the transformative impact our technology is having on medical diagnostics and patient care.

Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.

Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.

Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.

Enhance the effectiveness of antimicrobial use in hospitals by equipping prescribers and Antimicrobial Stewardship Program (ASP) members with our innovative AI-driven software, ZEVAC. The challenge of antibiotic resistance represents a critical public health concern today. ZEVAC is an advanced AMS software harnessing the power of AI to assist hospitals in eliminating unnecessary or improper antibiotic prescriptions. It employs a scientific yet unconventional methodology in combating the rise of antimicrobial resistance (AMR). By utilizing ZEVAC, clinicians can access precise and tailored antibiotic susceptibility predictions, which are informed by patient demographics, clinical details, local hospital prevalence, susceptibility trends, and historical culture data. In addition, ZEVAC empowers ASP members by providing proactive strategies to prevent inappropriate antimicrobial use through its real-time analysis of comprehensive hospital clinical data, ultimately fostering a more responsible approach to antibiotic stewardship. This multifaceted approach not only aids in individual patient care but also contributes to the broader goal of preserving antibiotic efficacy for future generations.

AarogyaAI is a software-as-a-service platform that utilizes artificial intelligence to identify drug-resistant tuberculosis (DR-TB) within hours. Our goal is to provide rapid and precise diagnoses of DR-TB, ensuring that patients receive the most effective drug combinations for their treatment without delay. Tuberculosis is responsible for more fatalities annually than AIDS, largely because the 19 available anti-TB medications do not work for all patients, leading to uncertainty among doctors regarding the appropriate treatment options. Consequently, even though tuberculosis is treatable, a delayed diagnosis of drug-resistant forms can result in patients remaining on ineffective medications for as long as seven years. By diagnosing drug-resistant tuberculosis swiftly, we enable prompt and appropriate treatment prescriptions. Patients upload a DNA sequence to our platform, and our advanced machine learning algorithm processes this data to generate a detailed report on drug susceptibility status, allowing healthcare providers to make informed decisions about treatment. This innovative approach not only enhances patient outcomes but also aims to reduce the overall burden of tuberculosis on healthcare systems.

The integration of artificial intelligence is set to revolutionize the field of healthcare diagnosis. By leveraging AI and predictive analytics, we can achieve early detection of diseases and enhance diagnostic accuracy. Our cloud-based AI platform aims to make healthcare more affordable and accessible for everyone. Endimension Technology, a healthcare AI startup fostered at IIT Bombay, specializes in developing advanced algorithms that identify abnormalities and diseases from medical imaging. Our team comprises experts in machine learning, software engineering, and medical professionals from esteemed institutions. We are dedicated to creating AI-driven healthcare solutions that will significantly minimize the incidence of patient misdiagnosis. Furthermore, our technology is designed to alleviate the workload of radiologists while simultaneously improving the speed at which patients receive their results, ultimately leading to better healthcare outcomes. By harnessing the power of AI, we envision a future where diagnostic processes are more efficient and reliable.

Collaborating with top healthcare organizations, harrison.ai develops AI-based medical device solutions that significantly influence global health and promote excellence in clinical practices. We at harrison.ai are firm in our conviction that equitable access to high-quality healthcare is a basic human right that should be available to everyone, regardless of their location. To transform this vision into reality, we integrate medical knowledge with cutting-edge data engineering and leverage the capabilities of artificial intelligence (AI) to create a more just and promising future for healthcare. By uniting brilliant minds, we foster an environment that inspires exceptional work and innovative ideas. As a clinician-led organization specializing in healthcare artificial intelligence, we focus on designing efficient and accessible solutions and services. Our approach combines remarkable deep learning proficiency with hands-on clinical experience, allowing us to implement healthcare AI solutions that truly make a difference. In doing so, we aim to enhance patient outcomes and streamline healthcare processes globally.

Pulse is a cloud-based solution designed for echocardiography labs aiming to enhance efficiency and patient outcomes. This platform facilitates reporting, storage, and analysis of echocardiograms, ensuring that you can access patient information whenever and wherever it's needed. Physicians benefit from the ability to review studies and finalize reports from virtually any location, making it an essential tool for contemporary echocardiography practices. With a user-friendly and robust reporting interface conveniently located alongside images and measurements, Pulse empowers users to navigate their tasks seamlessly. Its AI-driven features allow for fully automated measurements of GLS, LVEF, LVEDV, and LVESV, eliminating the need for manual input. Furthermore, the platform minimizes security risks while maximizing the advantages associated with cloud-native technology. Reports can be sent directly to your electronic health record (EHR) via HL7, effectively streamlining clinical workflows. You can easily store new studies right from the cart or retrieve existing studies from an external PACS. Moreover, integrated support for DICOM-TLS simplifies the management of secure data access, sparing users from the complexities of VPN setups. Overall, Pulse is revolutionizing the way echocardiography labs operate by combining technology with clinical expertise.

Amazon Comprehend Medical is a natural language processing (NLP) service compliant with HIPAA that leverages machine learning to retrieve health information from medical texts without requiring any prior machine learning expertise. A significant portion of health data exists in unstructured formats such as physician notes, clinical trial documentation, and patient medical records. The traditional approach of manually extracting this data is labor-intensive and inefficient, while automated methods based on strict rules often overlook crucial contextual details, leading to incomplete data capture. Consequently, this limitation results in valuable information remaining untapped for large-scale analytical efforts that are essential for progressing the healthcare and life sciences sectors, ultimately impacting patient care and operational efficiencies. By addressing these challenges, Amazon Comprehend Medical enables healthcare professionals to harness their data more effectively for better decision-making and innovation.

RLD360™ is a comprehensive AI-powered platform built to support safer, higher-quality healthcare delivery. It brings together provider management, safety and risk management, regulatory compliance, and patient experience in one connected ecosystem. The platform provides leaders with real-time visibility into risk, performance, and outcomes. AI-powered analytics help organisations act sooner to prevent harm and reduce care variability. RLD360™ supports critical functions such as event reporting, root cause analysis, claims management, and safety huddles. Integrated compliance and standards tools help ensure consistent adherence to best practices. Provider management capabilities support credentialing, scheduling, and performance oversight. Patient experience tools capture feedback and support reputation growth. Secure data availability and archiving ensure information is preserved and accessible. Together, these capabilities help healthcare organisations drive efficiency, readiness, and continuous improvement.